We just completed our first institutional capital raise and have attracted Big Pharma talent to our Advisory Board. We have data coming shortly on our MANF Parkinson’s program and expect additional corporate milestones will be reached in the coming weeks. As we achieve these milestones, we believe we will be in a good position to up-list to a national exchange.
If you look back to the last time AMBS promised shareholders something moving forward (November 7th PR with 15, 30, 45 day milestones), they are pretty reliable at getting what they say they are going to do done. The CEO and employees are all shareholders themselves, so they are going to do everything in the best interest of this stock’s PPS.